Last reviewed · How we verify
NCT03204422
Estimation Method of 24-hour Urinary Sodium Excretion by Using Spot Urine for Chinese Population
trial testing No intervention in Urinary Sodium Excretion in 330 participants. Completed in 31 December 2021.
31 August 2021
Quick facts
| Lead sponsor | Beijing Children's Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 330 |
| Start date | 1 February 2017 |
| Primary completion | 31 August 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- No intervention
Conditions studied
- Urinary Sodium Excretion — all drugs for Urinary Sodium Excretion →
- Salt Intakes — all drugs for Salt Intakes →
Sponsor
Beijing Children's Hospital
Who can join
Adults 5 to 60, any sex, with Urinary Sodium Excretion or Salt Intakes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The accurate evaluation of daily salt or sodium intake is difficult to implement in clinical practice and large epidemiological studies. 24-h urinary sodium excretion (USE) is considered the gold standard, but is expensive and has a high participant burden. To further explore the association between 24-h USE and spot urines in Chinese population, it was proposed that using collected multiple spot urine samples could be estimated for 24-h USE in Chinese children and adults.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03204422
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No intervention
Trials testing the same drug.
- NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
- NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
- NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
- NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
- NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
Other Beijing Children's Hospital trials
Trials by the same sponsor.
- NCT07412119 — Research on Disease Control and Mental Health Status of Adolescent Asthma Patients · not yet recruiting
- NCT06837584 — Control and Treatment of Outpatient Children With Asthma · not yet recruiting
- NCT07199101 — Multicenter Pediatric Low-Dose CT Protocol: Development and Clinical Verification · NA · not yet recruiting
- NCT07488728 — Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-A · NA · recruiting
- NCT07029958 — Improved Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Protocol for the Treatment of Epstein Barr Vir · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03204422 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beijing Children's Hospital
- Last refreshed: 2 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03204422.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing